NFKB1 and cholangiocarcinoma: It has been reported that intracellular and extracellular IL-33 play distinct mechanistic roles; intracellular IL-33 attenuates extracellular IL-33-induced cholangiocarcinoma cell proliferation and invasion via NF-κB and GSK-3β pathways [48].